Author

Jean-Claude Brelière

Observed names: Jean Claude Brelière, Jean-Claude Breliere, Jean-Claude Breliére

Institution: Sanofi (France)

Observed institution: Sanofi (France)

OpenAlex ID: A5111621439

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1994 · Murielle Rinaldi-Carmona, Francis Barth, et al. · FEBS Letters · 1,762

In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

1993 · Xavier Emonds-Alt, Jean-Daniel Doutremepuich, et al. · European Journal of Pharmacology · 371

Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist

1995 · Murielle Rinaldi-Carmona, Francis Barth, et al. · Life Sciences · 307

Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain

1996 · Murielle Rinaldi-Carmona, Françoise Pialot, et al. · Life Sciences · 132

A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists

1993 · Claude A. Bernhart, Pierre M. Perreaut, et al. · Journal of Medicinal Chemistry · 113

Effects on the Isolated Human Bronchus of SR 48968, a Potent and Selective Nonpeptide Antagonist of the Neurokinin A (NK2) Receptors

1992 · Charles Advenier, Emmanuel Naline, et al. · American Review of Respiratory Disease · 109

Blockade of cannabinoid (CB1) receptors by SR 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils

1999 · M. Poncelet, Marie-Christine Barnouin, et al. · Psychopharmacology · 68

Immunopharmacological profile of SR 31747: In vitro and in vivo studies on humoral and cellular responses

1994 · Pierre Casellas, Bernard Bourrié, et al. · Journal of Neuroimmunology · 49

Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonists

1996 · Jean-Marie Derocq, Michel Ségui, et al. · FEBS Letters · 46

Allosteric modulation of peripheral sigma binding sites by a new selective ligand: SR 31747

1994 · Raymond Paul, Serge Lavastre, et al. · Journal of Neuroimmunology · 40

Effects of 1-hydroxyethylidene-1,1 bisphosphonate and (chloro-4 phenyl) thiomethylene bisphosphonic acid (SR 41319) on the mononuclear cell factor-mediated release of neutral proteinases by articular chondrocytes and synovial cells

1985 · Xavier Emonds-Alt, Jean-Claude Brelière, et al. · Biochemical Pharmacology · 40

Turning behavior induced in mice by a neurokinin A receptor agonist: Stereoselective blockade by SR 48968, a non-peptide receptor antagonist

1993 · Martine Poncelet, Christiane Gueudet, et al. · Neuroscience Letters · 35

SR 48968, a neurokinin A (NK2) receptor antagonist

1993 · Xavier Emonds-Alt, Charles Advenier, et al. · Regulatory Peptides · 34

The NK2 receptor antagonist SR48968 inhibits thalamic responses evoked by thermal but not mechanical nociception

1993 · Vincent Santucci, Christiane Gueudet, et al. · European Journal of Pharmacology · 31

Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist

1993 · Murielle Rinaldi-Carmona, Monsif Bouaboula, et al. · European Journal of Pharmacology Molecular Pharmacology · 29

Identification of binding sites for SR 46349B, a 5-hydroxytryptamine2 receptor antagonist, in rodent brain

1994 · Marielle Rinaldi-Carmona, Christian Congy, et al. · Life Sciences · 26

Dihydro-imidazolone derivatives as angiotensin II receptor antagonists: chiral effect on the activity

1994 · Pierre Perreaut, Jacques Clément, et al. · Bioorganic & Medicinal Chemistry Letters · 1

Works count: 17

Citation count: 3,193

H-index: 16

I10-index: 16